Ariela Knallevsky, MD

Executive Medical Director, Medical Affairs

Ariela Knallevsky, MD, Executive Medical Director, Medical Affairs at Worldwide Clinical Trials brings more than two decades of leadership experience in the healthcare and pharmaceutical space. She is passionate about the medical research field and ensures that commitment and passion are reflected in her entire team.

Ask Dr. Knallevsky a question

Submit an RFP. Ask a Question

Dr. Knallevsky has more than 20 years’ of clinical practice experience as well as 23 years of clinical research experience. As an investigator, she participated in several clinical studies in different indications, such as osteoporosis, diabetes, insomnia, among others.

She began her career in research as a sub-investigator, moving into the therapeutic medical advisory field for more than 10 years. She was responsible for overseeing all medical aspects in Phase I studies, Phase II studies, Phase III studies, and Phase IV studies. She also has medical data review and safety review experience.

Dr. Knallevsky has served as a medical monitor and investigator in several studies in the rheumatology & immunology area, focusing on rare diseases (short bowel syndrome in pediatric population; eosinophilic esophagitis, Fabry disease, Severe Hidradenitis Suppurativa, lupus nephritis, and others.) She also has experience in COVID-19 trials and rheumatology clinical trials using biosimilar therapies and due diligences.

Dr. Knallevsky has a diploma in medicine from the Universidad de Buenos Aires where she also completed her residency. She is board certified in internal medicine and received one of her master's degrees in pharmacological and clinical research at Universidad Abierta Interamericana and the other in Osteology and Mineral Metabolism at Universidad Del Salvador.

Want to learn more about Worldwide Clinical Trials?